Clinical Trial Update: Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial at MD Anderson is evaluating the feasibility, safety, and efficacy of genetically engineered glucocorticoid receptor knockout virus-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Bk Virus Infection
• COVID-19 Infection
• Cytomegalovirus Infection
• Hematologic Malignancy
• Jc Virus Infection
• Malignant Solid Neoplasm

Drugs mentioned

• Genetically Engineered Glucocorticoid Receptor Knock Out Virus-Specific CTL Lines

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Adenovirus Infection, BK Virus Infection | Phase 1 | Status: RECRUITING